Discover 745 paid clinical trials in British Columbia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 745
Active & ResponsiveNew
A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant
for
Respiratory Syncytial Virus Infections
Location: Vancouver, St Louis MO
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07092865
Phase2, Recruiting
Active & Responsive
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
for
Cervical Cancer,
Location: Vancouver, Portland OR, Edmonton, Clovis CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT04895709
Phase1, Phase2, Recruiting
Active & Responsive
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Kelowna, Vancouver, Vancouver WA, Portland OR,
Sponsor: Celgene
Sex: Male
Age: 18+
Code: NCT06764485
Phase3, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)
for
Alzheimer Disease, Dementia
Location: Kelowna, Bellevue WA, Portland OR, Sherman Oaks CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 55 - 70+
Code: NCT06721156
Phase2, Recruiting
Active & Responsive
Mobile Health to Enhance Exercise in Type 2 Diabetes
for
Diabetes Mellitus, Type 2, Telemedicine, Mobile Applications,
Location: Kelowna
Sponsor: University of British Columbia
Sex: All
Age: 40 - 70+
Code: NCT04653532
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Kelowna, Spokane WA, Victoria, Berkeley CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136559
Phase3, Recruiting
Active & Responsive
A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors
for
Solid Tumor
Location: Vancouver, Denver CO, Chicago IL, Grand Rapids MI,
ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions
for
Myelodysplastic Syndromes
Location: Vancouver, Kennewick WA, Calgary, Walnut Creek CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT05949684
Phase3, Recruiting
Active & Responsive
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)